With a New Identity, Travere Thearpeutics Seeks to Find Its True Path
RARECast - Een podcast door RARECast - Donderdagen
Categorieën:
Eric Dube, CEO of Travere Therapeutics, discusses the company’s new identity, its experimental therapy sparsentan, and the rare kidney diseases it is being developed to treat.
